Measurement of (1-3)-.BETA.-D-Glucan Derived from Different Gauze Types
- 1 January 2009
- journal article
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 217 (2) , 117-121
Abstract
(1-3)-beta-D-glucan (BDG) is a cell-wall polysaccharide component found in most fungi. The measurement of BDG is a useful diagnostic marker for invasive fungal infections. However, it is well known that interfering substances can result in false positive reactions. We encountered a patient who underwent lung transplantation and presented with highly elevated BDG values, despite having no evidence of invasive fungal infection. We therefore hypothesized that elevated BDG values were originated from the gauze products used during surgery. While it is known that gauze products contain BDG, there have been no previous reports to quantitatively correlate amount of gauze usage and BDG levels. In this study, we extracted BDG from various gauze products and measured BDG to better understand the degree of which gauze contributes to elevated BDG values. Six types of commonly used surgical gauze products were selected for our study. Each of the surgical gauze was immersed in sterile, purified water for up to 120 minutes. At set intervals, BDG values in the water extracts were measured. Purified water samples without gauze were used as negative controls (< 4 pg/ml). After 120-minute extraction, BDG levels varied greatly depending on gauze products, ranging from 11.7 pg/ml to 6612 pg/ml. The gauze made of lyocell, which is a fiber produced from wood pulp cellulose, yielded the lowest levels of BDG, and probably would not cause false positive for fungal infections. There is a need for the development of a gauze product that does not contribute to elevated BDG values.Keywords
This publication has 20 references indexed in Scilit:
- Reactivity of (1→3)-β- d -Glucan Assay with Commonly Used Intravenous AntimicrobialsAntimicrobial Agents and Chemotherapy, 2006
- Interference of (1.RAR.3)-.BETA.-D-glucan Administration in the Measurement of Plasma (1.RAR.3)-.BETA.-D-glucanInternal Medicine, 2004
- Experimental proof of contamination of blood components by (1?3)-?-D-glucan caused by filtration with cellulose filters in the manufacturing processJournal of Artificial Organs, 2003
- Comparison of Four Diagnostic Methods Using Clinical Blood by Measuring (1^|^rarr;3)-^|^beta;-D-GlucanKansenshogaku Zasshi, 2003
- Elevation of Blood (1→3)-Beta-D-Glucan Concentrations in Hemodialysis PatientsNephron, 2001
- Influence of various hemodialysis membranes on the plasma (1→3)-β-D-glucan levelKidney International, 2001
- Membrane and cell wall targets in Aspergillus fumigatusDrug Resistance Updates, 2001
- Comparison between Wako-WB003 and Fungitec G tests for detection of (1→3)-β-D-glucan in systemic mycosisJournal of Clinical Laboratory Analysis, 1997
- (1 → 3)-β-Zeitschrift für Die Gesamte Experimentelle Medizin, 1997
- Plasma (1→3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodesThe Lancet, 1995